Sucralfate

Mucositis, Curling Ulcer, Indigestion + 9 more

Treatment

2 FDA approvals

20 Active Studies for Sucralfate

What is Sucralfate

Sucralfate

The Generic name of this drug

Treatment Summary

Sucralfate is a medication used to prevent and treat a variety of gastrointestinal disorders, such as duodenal ulcers, GERD, gastritis, peptic ulcer disease, and dyspepsia. It works by protecting cells in the gastrointestinal tract from damage caused by substances like stomach acid, bile salts, alcohol, and aspirin. Sucralfate is safe and well-tolerated and comes in both tablet and suspension forms. It was approved by the FDA in 1982 for tablets and 1994 for suspension.

Carafate

is the brand name

image of different drug pills on a surface

Sucralfate Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Carafate

Sucralfate

1981

91

Approved as Treatment by the FDA

Sucralfate, otherwise known as Carafate, is approved by the FDA for 2 uses like active Duodenal ulcer and Duodenal Ulcer .

active Duodenal ulcer

Duodenal Ulcer

Effectiveness

How Sucralfate Affects Patients

This drug helps heal duodenal ulcers by creating a protective barrier between the lining of the gastrointestinal tract and any harmful substances. It also accelerates the healing process by increasing the levels of growth factors and prostaglandins in the area.

How Sucralfate works in the body

Sucralfate helps heal duodenal ulcers, but exactly how it works is not yet known. Studies suggest that it binds to proteins and fibrinogen on the surface of ulcers, protecting them from the harmful effects of stomach acid. It also seems to increase growth factors and prostaglandins in the tissue to promote healing. In the lab, a sucralfate-albumin film helps block hydrogen ions from entering ulcers. In humans, sucralfate also decreases pepsin activity, which can damage tissues, and it can adsorb bile salts which can cause further injury

When to interrupt dosage

The suggested dose of Sucralfate is reliant upon the diagnosed issue, for example, Healing, Mucositis and Indigestion. The measure of dosage differs, as per the technique of presentation featured in the table below.

Condition

Dosage

Administration

Mucositis

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Curling Ulcer

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Indigestion

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Gastritis

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Duodenal Ulcer

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Healing

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Chemotherapy

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Stomach Ulcer

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Peptic Ulcer

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Stress Ulcers

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Anti-platelet Therapy

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Heartburn

, 1000.0 mg, 100.0 mg/mL, 1000.0 mg/mL, 1.8 mg/mL

Tablet, Tablet - Oral, , Oral, Suspension, Suspension - Oral, Cream - Topical, Cream, Topical

Warnings

Sucralfate Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Sucralfate may interact with Pulse Frequency

There are 20 known major drug interactions with Sucralfate.

Common Sucralfate Drug Interactions

Drug Name

Risk Level

Description

Deferasirox

Major

Sucralfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.

Raltegravir

Major

Sucralfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.

Technetium Tc-99m oxidronate

Major

The serum concentration of Technetium Tc-99m oxidronate can be increased when it is combined with Sucralfate.

Abacavir

Minor

Sucralfate may decrease the excretion rate of Abacavir which could result in a higher serum level.

Abafungin

Minor

Sucralfate can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy.

Sucralfate Toxicity & Overdose Risk

Overdosing on Sucralfate is rare and has not been reported in humans. Consuming too much of the drug may cause constipation and require supportive care. The drug is classified as a pregnancy Category B drug, meaning that studies in animals have not revealed any harm to the fetus - however, there have been no clinical trials in pregnant women. It is unknown whether this drug is excreted in breast milk, so caution should be taken if a lactating or nursing woman takes the drug. Tests on rodents have revealed no signs of drug-related tumors at doses up to 12 times the recommended human dose.

image of a doctor in a lab doing drug, clinical research

Sucralfate Novel Uses: Which Conditions Have a Clinical Trial Featuring Sucralfate?

46 investigations are currently in progress to assess the potential of Sucralfate for Heartburn, Dyspepsia and Anti-platelet Agents.

Condition

Clinical Trials

Trial Phases

Chemotherapy

4 Actively Recruiting

Phase 1, Phase 3, Not Applicable

Peptic Ulcer

0 Actively Recruiting

Curling Ulcer

0 Actively Recruiting

Indigestion

6 Actively Recruiting

Phase 3, Not Applicable, Phase 2

Stress Ulcers

0 Actively Recruiting

Duodenal Ulcer

0 Actively Recruiting

Anti-platelet Therapy

0 Actively Recruiting

Gastritis

0 Actively Recruiting

Stomach Ulcer

2 Actively Recruiting

Phase 4, Not Applicable

Healing

0 Actively Recruiting

Heartburn

14 Actively Recruiting

Phase 3, Phase 2, Not Applicable, Phase 1

Mucositis

1 Actively Recruiting

Not Applicable

Sucralfate Reviews: What are patients saying about Sucralfate?

5

Patient Review

4/6/2022

Sucralfate for Condition in which Stomach Acid is Pushed Into the Esophagus

If you're struggling to get a large pill down, this medication comes in liquid form. Ask your pharmacy for more information.

5

Patient Review

6/6/2021

Sucralfate for Heartburn

This is one of the best heartburn treatments I've ever tried.

4.7

Patient Review

3/30/2022

Sucralfate for Condition in which Stomach Acid is Pushed Into the Esophagus

I only started taking this medication today to help with my acid reflux, which has been really bad for a few weeks now. I'm not sure if I have ulcers or gastritis yet since I haven't seen the specialist yet, but after only two doses of this medication, I already feel so much better! It's such a relief after all these weeks of being in agony. My stomach is still burning a bit, but overall I'm feeling much better.

4.7

Patient Review

2/1/2017

Sucralfate for Condition in which Stomach Acid is Pushed Into the Esophagus

I had to have surgery to fix a stomach valve defect, and afterwards my reflux/GERD got worse. Omeprazole helped but my esophagus was raw. Sucralfate has solved the problem for me; however, I've developed diarrhea recently so I am stopping taking the medication temporarily to see if that solves the issue.

4.7

Patient Review

9/5/2022

Sucralfate for Inflammation of Esophagus from Backflow of Stomach Acid

Super easy to use and completely effective. I would definitely recommend this to anyone who has trouble swallowing pills!

4.3

Patient Review

8/3/2021

Sucralfate for Inflammation of Esophagus from Backflow of Stomach Acid

This medication has been a literal lifesaver for me. I get periodic pain in my stomach and throat that's linked to inflammation. One pill usually does the trick overnight, though they are large. You can also dissolve them in water, which is what I do.

4

Patient Review

10/9/2022

Sucralfate for Heartburn

I've only been taking this for two days, but I'm already careful of the aluminum content. I don't have an ulcer or pain like most people; I just get acid heartburn. I got off Prilosec because it's not good for you in the long run.

4

Patient Review

6/8/2018

Sucralfate for Condition in which Stomach Acid is Pushed Into the Esophagus

The pill is large, but if you cut it in half it's much easier to swallow.

3.3

Patient Review

1/3/2021

Sucralfate for Inflammation of the Gums and Mouth

I've been struggling with Burning Mouth Syndrome for over a year and a half now. I've tried other treatments that have given me some relief, but recently I switched to sucralfate and noticed significant improvement.

3

Patient Review

12/12/2021

Sucralfate for Condition in which Stomach Acid is Pushed Into the Esophagus

The nausea this medication caused was really tough to manage. I had no appetite and nothing sounded good. I'm glad it's over.

3

Patient Review

2/18/2018

Sucralfate for Heartburn

I've nearly choked to death on these pills before, and would have if my husband wasn't there to help me. I have to cut them into fourths, and even then they still stick in my throat. They have a coating that's like an aspirin, which makes them difficult to swallow. The liquid version is much more expensive, but at least it wouldn't choke me.

2.3

Patient Review

4/7/2018

Sucralfate for Inflammation of Esophagus from Backflow of Stomach Acid

Although this medication is easy to take, I have experienced some very unpleasant side effects like nausea and bile in my mouth. My doctor says to take it before eating, but that hasn't alleviated the issue.

2

Patient Review

11/15/2021

Sucralfate for Stomach Ulcer

I have been in a lot of stomach pain for the past few days due to gastritis. I was prescribed this medication by my primary care manager, but every time I take it I feel terrible. I'm not sure why it isn't working for me, but I am doing everything else that is recommended (like staying hydrated and eating yogurt). Maybe it just takes some time?

1.7

Patient Review

2/8/2021

Sucralfate for Heartburn

Nausea and dizziness was so severe that I couldn't continue the treatment.

1.3

Patient Review

7/19/2021

Sucralfate for Heartburn

I find myself really struggling with hunger since starting this medication.

1

Patient Review

6/13/2022

Sucralfate for Stomach Ulcer

I was prepared to take this medication until I read about some of the more serious side effects on Wikipedia. These aren't listed under general side effects and they're pretty scary!

1

Patient Review

7/8/2022

Sucralfate for Heartburn

This medication made me nauseous and gave me stomach pain as soon as I took it.

1

Patient Review

4/24/2021

Sucralfate for Stomach Ulcer

This treatment is really hurting my stomach.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about sucralfate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When should sucralfate be taken?

"If you are taking sucralfate to prevent an ulcer from returning after it has healed, the tablets usually are taken twice a day. It is best to take sucralfate on an empty stomach, 2 hours after or 1 hour before meals. Try to take sucralfate around the same times every day."

Answered by AI

What is sucralfate used for?

"Sucralfate is a medication used to treat and prevent duodenal ulcers and other conditions. It works by forming a barrier over the ulcer, protecting it from the acid of the stomach and allowing it to heal."

Answered by AI

What is the most common side effect of sucralfate?

"The most common side effect of sucralfate is constipation. This is because the medication works by binding to ulcers to protect them from further exposure to stomach acid, bile, pepsin, and bile salts. This gives the ulcers time to heal."

Answered by AI

Clinical Trials for Sucralfate

Image of UPMC Hillman Cancer Center in Pittsburgh, United States.

Mobile App for Cancer

18+
All Sexes
Pittsburgh, PA

The goal of this study is to determine whether a mobile application that combines real-time sensor data and patient-reported symptoms to trigger care-team contact recommendations is feasible and beneficial for patients receiving chemotherapy. The main questions it aims to answer are: * Is the mobile application feasible and acceptable to patients? * Do the alerts and guidance improve symptom management, quality of life, and engagement with the care team during treatment? Participants will: * Complete a demographic questionnaire at the beginning of the study and quality-of-life and health questionnaires at the beginning, midpoint, and end of study. * Complete daily symptom ratings via study application. * Wear a Fitbit activity tracker for 90 days. * At the end of the study, complete a semi-structured interview to provide feedback on the study. * Optional: At the beginning and end of the study, complete an in-person physical function assessment measuring balance (Short Physical Performance Battery).

Waitlist Available
Has No Placebo

UPMC Hillman Cancer Center

Carissa A Low

Image of University of California, Irvine - UCI Medical Center in Orange, United States.

Sling-Fiber Preservation vs. Conventional POEM for Achalasia

18+
All Sexes
Orange, CA

Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.

Waitlist Available
Has No Placebo

University of California, Irvine - UCI Medical Center

Jason Samarasena, MD, MBA

Have you considered Sucralfate clinical trials?

We made a collection of clinical trials featuring Sucralfate, we think they might fit your search criteria.
Go to Trials
Image of Mayo Clinic in Rochester in Rochester, United States.

High Resolution Gastric Mapping and Gastroduodenal Manometry for Indigestion

18 - 80
All Sexes
Rochester, MN

Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensation. Therapeutic options manage symptoms, and there is no FDA approved medical therapy for dyspepsia. There is a need for better objective understanding of sensorimotor dysfunction in dyspepsia, as well as noninvasive, efficacious, safe, and inexpensive treatments for dyspepsia. The purpose of this research is to identify disturbances and characterize phenotypes in patients with functional dyspepsia, and to assess the correlations between symptoms (during the manometry and in daily life), gastric emptying, electrical activity (BSGM), and pressure activity (manometry).

Recruiting
Has No Placebo

Mayo Clinic in Rochester

Nicholas R Oblizajek, MD

Image of Medical College of Wisconsin in Milwaukee, United States.

Fosamprenavir + Sodium Alginate for GERD

18 - 64
All Sexes
Milwaukee, WI

The goal of this clinical trial is to learn if study drug Fosamprenavir-Sodium Alginate (FOS-SA) administered orally improves symptoms for Proton Pump Inhibitor (PPI)-refractory Gastro Esophageal Reflux Disease (GERD). The main questions it aims to answer are: 1. Does FOS-SA significantly improve heartburn severity over the 8-week treatment period 2. Does FOS-SA significantly improve regurgitation frequency over the 8-week treatment period 3. Does FOS-SA significantly improve symptoms of persistent GERD over the 8-week treatment period Researchers will compare FOS-SA to a placebo (a look-alike substance that contains no active drug) to see if FOS-SA works to treat PPI-refractory GERD. Participants will: 1. Take FOS-SA or placebo every day BID (twice a day) for 8 weeks 2. Visit the Adult Translational Research Unit (ATRU) seven times for consenting, screening, and checkups and tests 3. Keep a daily diary of their symptoms of persistent GERD

Phase 2
Waitlist Available

Medical College of Wisconsin

Nikki Johnston, PhD.

Image of Brigham and Women's Hospital in Boston, United States.

Low Thermal Plasma for Marginal Ulcers

18+
All Sexes
Boston, MA

The objective of the study is to investigate the treatment of marginal ulcers with Low Thermal plasma in an endoscopic setting. By a treatment of the ulcerated areas with argon plasma with low power settings (\~ 1 W) we hypothesize that the size of the ulcers will shrink, and the healing is accelerated compared to standard of care alone. Patients will benefit from this minimally invasive approach compared to a much more invasive surgical approach that comes with higher risks and hospital stay length time. From a societal and scientific perspective, this study aims to extend the well-documented clinical benefits of plasma technology - from external wound healing to internal ulcer treatment - within an endoscopic framework. The success of this study could pave the way for broader applications of LTP in the treatment of other endoscopically accessible conditions such as peptic ulcers, duodenal ulcers and esophageal ulcers. This advancement has the potential not only to improve patient outcomes through less invasive methods, but also to position LTP as a cornerstone in the future of gastroenterological wound management strategies.

Recruiting
Has No Placebo

Brigham and Women's Hospital

Christopher C. Thompson, MD, MSc

Have you considered Sucralfate clinical trials?

We made a collection of clinical trials featuring Sucralfate, we think they might fit your search criteria.
Go to Trials
Image of Cleveland Clinic Center for Abdominal Core Health in Cleveland, United States.

Mesh vs Pledgets for Hernia Repair

18+
All Sexes
Cleveland, OH

The goal of this clinical trial is to compare whether the use of Ovitex mesh provides superior reduction in 2-year recurrence compared to pledgeted suture closure (no mesh) for patients undergoing paraesophageal hernia repair at the Cleveland Clinic. The main questions it aims to answer are: * Determine whether there is a difference in 2-year rates of radiographic recurrence with Ovitex versus pledgeted sutures in paraesophageal hernia repair. * Assess patient quality of life (QOL) after paraesophageal hernia repair with pledgets and mesh. A two-tailed research hypothesis will be used to determine whether there are differences between the two arms

Recruiting
Has No Placebo

Cleveland Clinic Center for Abdominal Core Health

David M Krpata, MD

Have you considered Sucralfate clinical trials?

We made a collection of clinical trials featuring Sucralfate, we think they might fit your search criteria.
Go to Trials